The organometallic tridentate ketoamine or enaminone compound, (η 5 -Cp)Fe(η 5 -C 5 H 4 )-C(=O)-CH=C(Me)-NH-C 6 H 4 -o-NH 2 , undergoes an intramolecular cyclocondensation promoted by Cu(ClO 4 ) 2 ⋅6H 2 O (2:1 molar ratio) affording the neutral 2-ferrocenyl-4-methyl-1,5-benzodiazepine, 1. However, when the molar ratio used is 1:1, the ketoamine or enaminone compound transforms into the 2-ferrocenyl-4-methyl-1,5-benzodiazepinium cation, [2] + . The X-ray molecular structure of 1 exhibits a seven-membered ring with a boat conformation, and two folding dihedral angles along the N(1)-N(2) and C(11)-C (13) + is provided through DFT calculations.
INTRODUCTION
It is well known in the literature that reactions of β-diketones with 1,2-diamines generally yield symmetrical 2:1 tetradentate Schiff bases whatever their proportion. 1 However, relatively few studies on tridentate 1:1 condensation products have been reported.
2 These compounds, synthesized by a single condensation reaction of a carbonyl function of a β-diketone with only one amine group of an aliphatic or aromatic 1,2-diamine, are referred to as "half units" or "hemi-Schiff bases" and in solution they can exist as a tautomeric mixture of the keto-amine (enaminone) and keto-imine (iminone) forms (Scheme 1, a and b, respectively). Nowadays, the interest on the development of these "half units", containing a free NH 2 group at one end of the molecule (Scheme 1), stems from their synthetic potential as precursors for the preparation of unsymmetrical tetradentate Schiff base ligands and their corresponding metal complexes. 3 On the other hand, considering the importance of the ferrocenyl fragment as a strong electron-releasing group 4 and the interesting electronic features exhibited by tridentate ferrocene-based keto-amines and their metal complexes, 5 we have initiated a systematic study on the reactivity of ONN tridentate "half units" synthesized by reaction of ferrocenoylacetone, Fc-C(=O)-CH 2 -C(=O)-Me, Fc= (η 5 -C 5 H 5 )Fe(η 5 -C 5 H 4 )-, with aromatic 1,2 diamines. As part of this work we report herein (i) the cyclocondensation of Fc-C(=O)-CH=C(Me)-NH-C 6 H 4 -o-NH 2 into 2-ferrocenyl-4-methyl-1,5-benzodiazepine, 1, and 2-ferrocenyl-4-methyl-1,5-benzodiazepinium cation, [2] + , promoted by copper(II), (ii) the molecular structures of complexes 1 and [2] + solved by single crystal X-ray diffraction analysis and, (iii) a DFT calculation which provides a rationalization of the electrochemical and spectroscopic properties of complexes 1 and [2] + . The synthesis of these compounds represents an important entry toward the preparation of organometallic 1,5-benzodiazepine and 1,5-benzodiazepinium compounds with potential pharmacological properties. 6 In fact, many classical members of organic 1,5-benzodiazepines are widely used as antianxiety, analgestic, sedative, antidepresive and hypnotic agents.
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EXPERIMENTAL SECTION
General data
Solvents were dried and distilled under dinitrogen by standard methods prior to use. Reagents were purchased from commercial suppliers and used without further purification. Ferrocenoylacetone, Fc-C(=O)-CH 2 -C(=O)-Me, was synthesized according to published procedures with some slight modifications. 8 Ferrocenyl-ketoamine ("half unit"), Fc-C(=O)-CH=C(Me)-NH-C 6 H 4 -o-NH 2 , was synthesized according to a procedure described in our Laboratory. 9 Microanalytical data were obtained on a Perkin Elmer model 2400 elemental analyzer. IR spectra were obtained as KBr disks on a Perkin Elmer model 1600 FT-IR spectrophotometer, in the range of 4000-450 cm -1 . Electronic spectra were recorded in CH 2 Cl 2 and MeOH solutions with a Spectronic, Genesys 2, spectrophotometer. 1 H-NMR spectra were acquired at 297 K on a multinuclear Bruker AC 400 spectrometer in (CD 3 ) 2 CO; chemical shifts were referenced using the chemical shifts of residual solvent resonances. Variable-temperature 1 H-NMR spectra were recorded in the 223-323 K range. Electrochemical measurements were performed using a Radiometer Analytical model PGZ 100 all-in-one potentiostat, using a standard three-electrode setup with a vitreous carbon working electrode, platinum wire auxiliary electrode and Ag/Ag + (0.1 M AgNO 3 in MeCN) as the reference electrode. MeCN solutions were 1.0 mM in the compound under study and 0.1 M in the supporting electrolyte n-Bu 4 N + PF 6 -with the voltage scan rate = 100 mVs -1 . Under these experimental conditions the Cp 2 Fe 0/+ couple was located at 0.089 V (ΔE = 70 mV). E 1/2 is defined as equal to (E pa + E pc )/2, were E pa and E pc are the anodic and cathodic peak potentials, respectively. Melting points were determined in evacuated capillaries and were not corrected. 2-ferrocenyl-4-methyl-1,5-benzodiazepine, 1: A Schlenk tube was charged with a magnetic stirring bar and a solution of 100 mg (0.28 mmol) of the ferrocenyl keto-amine in 20 mL of MeOH, then a solution of 51.5 mg (0.14 mmol) of Cu(ClO 4 ) 2 ⋅6H 2 O dissolved in 10 mL of MeOH, was added drop wise developing immediately a dark red color. The reaction mixture was stirred for 1 h. The resulting solution was concentrated under vacuum until a solid was formed. The brown reddish crude solid was dissolved in 10 mL of CH 2 Cl 2 , filtrated and evaporated to dryness. Suitable single crystals for X-ray diffraction studies were obtained from MeCN. Yield: 58.1 mg (67% Table 1 . Complete details of the crystal, X-ray data collection, and structure solution are provided as Supporting Information. Semi-empirical corrections, via ψ-scans, were applied for absorption. Intensity data were collected on a Bruker Smart Apex diffractometer equipped with a bidimensional CCD detector using graphite monochromated Mo-Kα radiation (λ=0.71073 Å). The diffraction frames were integrated using the SAINT package, 10 and corrected for absorption with SADABS. 11 The structure was solved using XS in SHELXTL-PC 12 by direct methods and completed (non-H atoms) by difference Fourier techniques. Refinement was performed by the full-matrix least-squares method based on F 2 . All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were placed in their calculated positions, assigned fixed isotropic thermal parameters and allowed to ride on their respective parent atoms. The perchlorate anion in [2] + ClO 4 -. CH 2 Cl 2 was disordered over two positions, with occupation multiplicity µ = 0.53/0.47.
Computational Details
DFT 13 calculations were carried out using the Amsterdam Density Functional (ADF) program.
14 The Vosko-Wilk-Nusair parametrization 15 was used to treat electron correlation within the local density approximation, with gradient corrections added for exchange 16 and correlation, 17 respectively. The numerical integration procedure applied for the calculation was developed by te Velde. 18 The standard ADF TZP basis set was used for all the atoms. The frozen core approximation was used to treat core electrons at the following level: Fe, 3p; C, 1s; N, 1s and O, 1s.
13d Full geometry optimizations were carried out on each complex using the analytical gradient method implemented by Verluis and Ziegler. 19 The geometry for all the model compounds discussed in the text was fully optimized, with a good agreement between the computed geometric parameters and the available structural data. Unrestricted formalism was used for the odd electron number compounds. -·CH 2 Cl 2 were solved by single crystal X-ray diffraction analysis (vide infra).
RESULTS AND DISCUSSION
Scheme 2
The most peculiar feature observed in the IR spectrum of [2] + ClO 4 -·CH 2 Cl 2 is the presence of two sharp bands of medium and weak intensities at 3309 and 3243 cm -1 , respectively, corresponding to the stretching modes of the NH groups of the 1,5-benzodiazepinium cation. These bands are, obviously, absent in complex 1. Likewise, a very large and strong band at 1108 cm -1 along with the medium intensity band at 758 cm -1 , attributed to the ν 3 (T 2 ) and ν 4 (T 2 ) modes of the ClO 4 -counteranion 21 have also been observed. On the other hand, complex 1 exhibits three characteristic bands of medium intensity at (i) 1634 and 1602 and (ii) 1575 cm -1 , assigned to the ν(C=N) and ν(C=C) stretching modes, respectively. The C=N bonds, according to the X-ray structure, are localized in the seven-membered ring (vide infra). -·CH 2 Cl 2 , recorded in (CD 3 ) 2 CO, at room temperature, are also consistent with their molecular structures. One of the more remarkable features of complex 1 is the presence of a broad singlet at 3.15 ppm, attributed to the methylene proton resonances of the 1,5-diazepine ring. In order to get a deeper insight into this peculiarity, the variable-temperature 1 H-NMR spectroscopic study was carried out in the temperature range 223-323 K. In the low temperature (223 K) the two doublets at δ 2.13 and 4.08 (J H-H = 10.86 Hz) are attributable to the geminal protons of the CH 2 group. When the temperature is raised the two doublets undergo coalescence at 268 K and then, at 323 K, transform into a sharp singlet at δ 3.11 ( Figure 1 ). The free energy of activation associated to the fluxional process involving the methylene group of the seven-membered ring was calculated at the coalescence temperature 22 and found to be 48.7 kJmol -1 .
On the other hand, the , the redox potential of the ferrocenyl group is strongly shifted to the anodic region. The high potential, E ½ = 0.450 V (∆E = 70 mV), reflects the strong electron-accepting capability of the positive delocalized seven-membered ring. In addition, an irreversible one-electron reduction wave was also observed in complex [2] + at E pc = -1.168 V which correspond to the NH proton reduction and the simultaneous generation of the neutral 1,5-benzodiazepine. The absence of this cathodic wave when NaOMe is added to the cell solution, is an empirical demonstration of this attribution. 23 The spectra of these complexes, performed in solvents of different polarity, such as CH 2 Cl 2 (ε=8.90) and MeOH (ε=32.63), exhibit five absorption bands. In CH 2 Cl 2 , the complexes exhibit a prominent absorption band in the range 310-340 nm, assigned to π-π* transitions (ILCT). In the case of complex 1 this band is blue-shifted in MeOH by 10 nm, while in complex [2] + this band is not affected. On the other hand, the broad lower energy band, at 462 and 570 nm, respectively, is attributed to a metal-to-ligand charge-transfer (MLCT) transition and it is strongly influenced by the nature of the acceptor. This assignment is in accordance with the latest theoretical treatment reported by Barlow et al. 24 and with the previously cited experimental work, although the assignment may be controversial. 25 In both complexes this band is blue-shifted by 8-9 nm in MeOH. -and CH 2 Cl 2 have been omitted for clarity. Thermal ellipsoids are drawn at 50% probability. The X-ray molecular structure of 1 exhibits a seven-membered ring with a boat conformation, and two folding angles along the N(1)-N(2) and C(11)-C(13) axes of 145.2 and 125.7°, respectively. Two localized double bonds for C(11)-N(1) = 1.281(4) and C(13)-N(2) = 1.277(4) A�, are also observed. On the other hand, the more remarkable structural feature of cation [2] + is the nonplanar seven-membered ring with a folding dihedral angle of 14. 
Theoretical studies
The study of complex [2] + indicates that the delocalized form of 2-ferrocenyl-4-methyl-1,5-benzodiazepinium cation, [2] + , Scheme 3a, is 0.83 eV (19 kcal mol -1 ) and 0.67 eV (16 kcal mol -1 ) more stable than the hypothetical localized iminium forms of the cations showed in Schemes 3b and 3c. Although the slight difference in terms of energy between the three forms of the molecule the most stable delocalized cationic form is observed both in solid state and solution. ) and reduced species ([1] -, 2). We have also computed their electronic structures. Figure 5 shows an energy levels diagram for 1 and [2] + . It is clear that the HOMO has, in both cases, a highly ferrocenyl character, which agrees with the experimental observation of an oxidation wave mainly related to this molecular fragment. On the other hand, LUMO has, in both cases, a main benzodiazepine ring character, relating the reduction wave to this molecular fragment. The computed HOMO-LUMO gap is almost the half on going from the neutral benzodiazepine, 1, to the protonated benzodiazepinium cation, [2] + , (2.09 vs 1.10 eV). Just considering in a first approach the gap as an indicative of the ease or difficulty to reduce a molecule, these results suggest the reduction of 1 is more expensive in energy compared to [2] + . Accordingly, it is observed that the reduction of [2] + occurs under the experimental conditions utilized while the reduction corresponding for 1 is not observed into the solvent window limit. The disappearance of the reduction wave of [2] + after the addition of a strong base (removal of H + from [2] + gives 1) also agrees with these results. Computed adiabatic oxidation/reduction potentials for 1 and [2] + are 6.54/0.89 and 9.68/4.95 eV, respectively, which confirms the gap previously suggested. Finally, it must be commented that the composition of HOMO and LUMO supports the assignment of a MLCT for both compounds, as discussed previously. The computed HOMO-LUMO gap is also consistent with a lower energy value for this transition in [2] + when compared to 1.
Concluding remarks
To summarize, as a result of our studies, we have found that the organometallic tridentate ketoamine or enaminone compound, Fc-C(=O)-CH=C(Me)-NH-C 6 H 4 -o-NH 2 , undergoes, under mild conditions, an intramolecular cyclocondensation promoted by copper(II) perchlorate hexahydrate into the neutral 2-ferrocenyl-4-methyl-1,5-benzodiazepine complex, 1, and into the cationic 2-ferrocenyl-4-methyl-1,5-benzodiazepinium species, [2] + , provided that the molar ratio is 2:1 or 1:1, respectively. To the best of our knowledge, complexes 1 and its protonated species [2] + are the first organometallic 1,5-benzodiazepines structurally characterized by X-ray diffraction analysis. Likewise, complex 1 and [2] + represent the first members of a new family of 2-ferrocenyl,4-methyl-1,5-benzodiazepines. 
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